Stock Research: Bio-Rad Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Bio-Rad Laboratories

NYSE:BIO US0905722072
36
  • Value
    75
  • Growth
    3
  • Safety
    Safety
    95
  • Combined
    71
  • Sentiment
    17
  • 360° View
    360° View
    36
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bio-Rad Laboratories develops, manufactures, and markets products for life science research and clinical diagnostics. It operates in the Life Science and Clinical Diagnostics industries. Its products are sold globally to hospital laboratories, diagnostic reference laboratories, and physician office laboratories. In the last fiscal year, the company had a market cap of $6784 million, profits of $1379 million, and revenue of $2567 million, with 7700 employees.

more
Index
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
75 61 60 49
Growth
3 3 9 17
Safety
Safety
95 97 86 96
Sentiment
17 13 36 61
360° View
360° View
36 25 45 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
37 40 69 88
Opinions Change
15 8 50 50
Pro Holdings
n/a 31 24 65
Market Pulse
52 40 43 16
Sentiment
17 13 36 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
75 61 60 49
Growth
3 3 9 17
Safety Safety
95 97 86 96
Combined
71 64 50 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
37 32 47 10
Price vs. Earnings (P/E)
68 64 57 50
Price vs. Book (P/B)
90 84 85 100
Dividend Yield
1 1 1 1
Value
75 61 60 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
14 12 20 7
Profit Growth
20 26 34 68
Capital Growth
7 11 29 27
Stock Returns
39 51 27 55
Growth
3 3 9 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
57 60 62 82
Refinancing
74 70 63 49
Liquidity
55 64 63 81
Safety Safety
95 97 86 96

Similar Stocks

Discover high‑ranked alternatives to Bio-Rad Laboratories and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: